Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review

Stroke is one of the world's leading causes of disability and death. Antiplatelet agents are administered to acute ischemic stroke patients as secondary prevention. Clopidogrel involves biotransformation by cytochrome P450 (CYP) enzymes into an active metabolite, and single nucleotide polymorph...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhazzani, Adel, Venkatachalapathy, Poongothai, Padhilahouse, Sruthi, Sellappan, Mohan, Munisamy, Murali, Sekaran, Mangaiyarkarasi, Kumar, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222621/
https://www.ncbi.nlm.nih.gov/pubmed/34177775
http://dx.doi.org/10.3389/fneur.2021.667234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222621/
https://www.ncbi.nlm.nih.gov/pubmed/34177775
http://dx.doi.org/10.3389/fneur.2021.667234

Ejemplares similares